Nordion Inc Com (NYSE:NDZ)

CAPS Rating: 4 out of 5

Global health and life sciences company that provides enabling technologies, products, and services to improve the delivery of healthcare worldwide. Primary focuses are drug development and disease diagnosis.


Player Avatar racoveanul (80.47) Submitted: 9/28/2007 1:37:48 PM : Underperform Start Price: $21.12 NDZ Score: +41.10

Conan Holder < 1.5 (bankruptcy risk > 75%), Altman for private companies Z score < 1.23. This company is in bad shape; other companies with valuation problems: BOW, CMS, TRY.B, LUK, LPX, SNSTA, TECUA, XRIT, CAR, VOD, GDP, MDZ, MCF, EPL, VMED, MIC, LINE, BKD ,AAV, EROC.

Featured Broker Partners